ALB · Albemarle Corporation

Albemarle delivered a materially stronger Q1 2026, with net sales rising 33% YoY to $1.4 billion and net income surging to $319 million — reversing prior-year losses and reflecting sharp improvements in both Energy Storage (sales up 70%, Adjusted EBITDA up 196%) and Specialties (sales up 12%, Adjusted EBITDA up 30%). The gains were driven primarily by elevated lithium pricing (+51% in Energy Storage), resilient bromine pricing in key emerging markets, and $40 million in realized cost and productivity improvements — on track to meet the full-year target of $100–$150 million. Management attributed the performance to disciplined execution amid ongoing geopolitical uncertainty, particularly supply chain disruptions in the Middle East. Notably, the company executed transformative capital allocation actions: it closed the sale of Ketjen and Eurecat for $648 million in net proceeds and paid down $1.3 billion of debt, lowering its weighted average interest rate and revising full-year interest expense guidance downward to $120–$140 million. This strengthened the balance sheet significantly, resulting in $2.7 billion of liquidity and a net debt-to-Adjusted EBITDA ratio of 1.0 as of March 31, 2026. While the Energy Storage outlook remains highly sensitive to lithium market pricing scenarios — with projected FY2026 net sales ranging from $4.1–$4.3 billion under the observed case ($10/kg LCE) to $7.5–$7.8 billion under the 2021–2025 average (~$30/kg LCE) — the Specialties segment outlook was upgraded on higher bromine pricing and recovery of Jordan Bromine Company operations post-flooding. CEO Kent Masters emphasized continued focus on operational excellence, cost discipline, and cash generation to navigate volatility and support long-term earnings growth.